Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Dynamic Neurotech Podcast

#13 Non-Invasive Neurotech/Signal Processing - Neudio & CorTec Founder: Joern Rickert

10 Oct 2024

Description

Interview with Dr. Joern Rickert. He is the CEO of Neudio, a non-invasive neurotechnology company focused on brain wave modulation and generating music from brainwaves, with the goal of improving mental well-being through personalized music experiences. This episode covers a wide range of interesting topics, where Dr. Rickert and I discuss: his background in neurotechnology and entrepreneurship from Cortec, the challenges and advantages of non-invasive vs. invasive neurotechnologies, the differences in signal processing, Neudio's 'closed-loop' approach to brain activity modulation, comparisons with other neurotechnology companies like Neurable, and future outlook for the company and the broader neurotechnology field. Recorded: May 2024. Host: Neil Raman Key Moments: 0:00 Introduction 0:57 Beginnings of Neudio + Transition from Cortec 3:18 Advantages of Non-Invasive Technologies 5:12 Drawbacks with Invasive Technology 8:48 Non-Invasive Advantages with Neudio 13:06 Evolution of Signal Processing and Effects in the Neurotech Field 15:30 Signal Processing with Neudio 17:44 Future Impacts with Neudio 19:48 Differentiating Neudio from Alternative Solutions/Companies 24:42 Next Steps with Neudio Links: Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe Joern Rickert LinkedIn: https://www.linkedin.com/in/joern-rickert-3386231a/ Neil Raman LinkedIn: https://www.linkedin.com/in/neil-raman21/ Neudio: https://www.neudio.com/ Ridge Biosignals: https://ridgebiosignals.beehiiv.com/subscribe

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.